SARS-CoV-2: Three Leading Microbiologists Discuss the Path Forward
Microbiologists at the Icahn School of Medicine at Mount Sinai, who created the first and most reliable test to determine whether an individual has antibodies to SARS-CoV-2, have been monitoring the virus since it began circulating in Wuhan, China, in late 2019. Now,...
Milestone Gift From Marc and Jennifer Lipschultz Elevates Precision Immunology Research at Mount Sinai
The Mount Sinai Health System has announced a transformative multimillion-dollar gift from Marc Lipschultz, who serves on Mount Sinai’s Boards of Trustees, and his wife, Jennifer, to the Precision Immunology Institute (PrIISM) at the Icahn School of Medicine at Mount...
Advancing Artificial Intelligence Through Philanthropy
Thanks to the outstanding generosity of the Windreich Family Foundation, the Icahn School of Medicine at Mount Sinai will advance its vision of integrating Artificial Intelligence (AI) and machine learning into research and clinical practice to amplify...
Mount Sinai Neuroscience Student Earns NIH Fellowship to Study Substance Use Disorders
Can the bacteria in your gut influence addictive behavior? That is the question that Katherine Meckel is studying and trying to answer. Currently a fifth-year PhD candidate in neuroscience at the Icahn School of Medicine at Mount Sinai, Ms. Meckel is one of 31 young...
Mount Sinai Researchers Describe a Novel Approach to Harness Fecal Microbiota Transplantation That Could Be Safer and More Precise
In a study published in Nature Microbiology, researchers at the Icahn School of Medicine at Mount Sinai address unanswered questions about how fecal microbiota transplantation (FMT) can effectively restore a patient’s microbiome. FMT involves transferring processed...
Brain Researcher Ian Maze Has Upended Scientific Dogma and Forged New Areas for Therapeutic Discovery
For decades, scientific dogma held that the chemicals dopamine and serotonin served as messengers within the central nervous system, allowing brain cells, or neurons, to communicate with each other. Known as neurotransmitters, dopamine and serotonin also contribute to...
Higher Risk of Autism Found in Babies Born Prematurely According to a Definitive New Mount Sinai Study
Premature birth is linked to an increased risk of autism spectrum disorder (ASD) in both males and females, with those born earliest carrying the highest risk, according to a large and definitive new study in Pediatrics from the Icahn School of Medicine at Mount...
Pandemic’s Toll on Mount Sinai Front-Line Staff Is Surveyed, and Addressed
Front-line staff who were already feeling burnout showed the most signs of mental distress during the height of the COVID-19 pandemic, while those who fared best had an active social network and felt supported by their supervisors. These were among the many lessons...
Mount Sinai Creates COVID-19 Vaccine for Low- and Middle-lncome Countries
The development of a safe, effective, and inexpensive COVID-19 vaccine that can easily be produced and distributed in low- and middle-income countries is underway at the Icahn School of Medicine at Mount Sinai, where early phase 1 clinical testing in Vietnam and...
